DrugPatentWatch Database Preview
Litigation Details for AbbVie Inc. v. Hetero USA Inc. (D. Del. 2013)
» See Plans and Pricing
AbbVie Inc. v. Hetero USA Inc. (D. Del. 2013)
| Docket | Start Trial | Date Filed | 2013-05-15 |
| Court | District Court, D. Delaware | Date Terminated | 2014-11-18 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | ABBVIE DEUTSCHLAND GMBH & CO. KG; ABBVIE INC.; HETERO LABS LIMITED; HETERO USA INC. | ||
| Patents | 6,037,157; 6,703,403; 7,148,359; 7,364,752; 8,268,349; 8,691,878 | ||
| Attorneys | Barbara R. Rudolph; Chad A. Landmon; Corinne Miller LaGosh; Derek James Fahnestock; Dominick T. Gattuso; Jennifer A. Johnson; Josephine Liu; Mary B. Graham | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AbbVie Inc. v. Hetero USA Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Details for AbbVie Inc. v. Hetero USA Inc. (D. Del. 2013)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2013-05-15 | 1 | ’349 patent”), United States Patent No. 6,037,157 (“the ’157 patent”), and United States Patent No. 6,703,403…FOURTH COUNT FOR PATENT INFRINGEMENT UNITED STATES PATENT NO. 6,037,157 83.…-417 nor patent owner of the ’359 patent, the ’752 patent, the ’349 patent, the ’157 patent or the ’403…action for patent infringement of United States Patent Number 7,148,359 B2 (“the ’359 patent”), United…United States Patent Number 7,364,752 B1 (“the ’752 patent”), United States Patent No. 8,268,349 B2 (“the | External link to document | |
| 2013-05-15 | 4 | ; 7,364,752 B1; 8,268,349 B2; 6,037,157; 6,703,403 B2;. (mdb) (Entered: 05/16/2013) 15 May 2013 … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359 B2; … 18 November 2014 1:13-cv-00852 830 Patent None District Court, D. Delaware | External link to document | |
| 2014-10-22 | 93 | AbbVie's Disclosure of Asserted Claims for U.S. Patent No. 8,691,878 B2 filed by AbbVie Inc., Abbvie Deutschland… 18 November 2014 1:13-cv-00852 830 Patent None District Court, D. Delaware | External link to document | |
| 2014-11-20 | 99 | ; 7,364,752 B1; 8,268,349 B2; 6,037,157; 6,703,403 B2. (Attachments: # 1 Order)(nms) (Entered: 11/20/2014… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359 B2; … 18 November 2014 1:13-cv-00852 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
